Ignite Creation Date:
2024-05-06 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06125080
Status:
RECRUITING
Last Update Posted:
2023-11-09
First Post:
2023-10-30
Brief Title:
The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer UTILIZABLE Single-arm Prospective Open Clinical Study
Sponsor:
Huihua Xiong
Organization:
Tongji Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| TNBC - Triple-Negative Breast Cancer |
Keywords: